Report Detail
Global Targeted Protein Degradation Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4682343 |
- 27 February, 2026 |
- Global |
- 93 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global Targeted Protein Degradation Drug market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Targeted Protein Degradation Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Targeted Protein Degradation Drug market size and forecasts, in consumption value ($ Million), 2021-2032
Global Targeted Protein Degradation Drug market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Targeted Protein Degradation Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Targeted Protein Degradation Drug market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Targeted Protein Degradation Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Targeted Protein Degradation Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Arvinas, Kangpu Biopharmaceuticals, Ranok Therapeutics, Accutar Biotechnology, BeiGene Ltd., Hinova Pharmaceuticals, Haisco Pharmaceutical, Nurix, Kymera Therapeutics, C4 Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Targeted Protein Degradation Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
PROTAC
Molecular Glue
Market segment by Application
Cancer
Autoimmune Diseases
Other
Market segment by players, this report covers
Arvinas
Kangpu Biopharmaceuticals
Ranok Therapeutics
Accutar Biotechnology
BeiGene Ltd.
Hinova Pharmaceuticals
Haisco Pharmaceutical
Nurix
Kymera Therapeutics
C4 Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Targeted Protein Degradation Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Targeted Protein Degradation Drug, with revenue, gross margin, and global market share of Targeted Protein Degradation Drug from 2021 to 2026.
Chapter 3, the Targeted Protein Degradation Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Targeted Protein Degradation Drug market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted Protein Degradation Drug.
Chapter 13, to describe Targeted Protein Degradation Drug research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Targeted Protein Degradation Drug by Type
- 1.3.1 Overview: Global Targeted Protein Degradation Drug Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Targeted Protein Degradation Drug Consumption Value Market Share by Type in 2025
- 1.3.3 PROTAC
- 1.3.4 Molecular Glue
- 1.4 Global Targeted Protein Degradation Drug Market by Application
- 1.4.1 Overview: Global Targeted Protein Degradation Drug Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Cancer
- 1.4.3 Autoimmune Diseases
- 1.4.4 Other
- 1.5 Global Targeted Protein Degradation Drug Market Size & Forecast
- 1.6 Global Targeted Protein Degradation Drug Market Size and Forecast by Region
- 1.6.1 Global Targeted Protein Degradation Drug Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Targeted Protein Degradation Drug Market Size by Region, (2021-2032)
- 1.6.3 North America Targeted Protein Degradation Drug Market Size and Prospect (2021-2032)
- 1.6.4 Europe Targeted Protein Degradation Drug Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Targeted Protein Degradation Drug Market Size and Prospect (2021-2032)
- 1.6.6 South America Targeted Protein Degradation Drug Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Targeted Protein Degradation Drug Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Arvinas
- 2.1.1 Arvinas Details
- 2.1.2 Arvinas Major Business
- 2.1.3 Arvinas Targeted Protein Degradation Drug Product and Solutions
- 2.1.4 Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Arvinas Recent Developments and Future Plans
- 2.2 Kangpu Biopharmaceuticals
- 2.2.1 Kangpu Biopharmaceuticals Details
- 2.2.2 Kangpu Biopharmaceuticals Major Business
- 2.2.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product and Solutions
- 2.2.4 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Kangpu Biopharmaceuticals Recent Developments and Future Plans
- 2.3 Ranok Therapeutics
- 2.3.1 Ranok Therapeutics Details
- 2.3.2 Ranok Therapeutics Major Business
- 2.3.3 Ranok Therapeutics Targeted Protein Degradation Drug Product and Solutions
- 2.3.4 Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Ranok Therapeutics Recent Developments and Future Plans
- 2.4 Accutar Biotechnology
- 2.4.1 Accutar Biotechnology Details
- 2.4.2 Accutar Biotechnology Major Business
- 2.4.3 Accutar Biotechnology Targeted Protein Degradation Drug Product and Solutions
- 2.4.4 Accutar Biotechnology Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Accutar Biotechnology Recent Developments and Future Plans
- 2.5 BeiGene Ltd.
- 2.5.1 BeiGene Ltd. Details
- 2.5.2 BeiGene Ltd. Major Business
- 2.5.3 BeiGene Ltd. Targeted Protein Degradation Drug Product and Solutions
- 2.5.4 BeiGene Ltd. Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 BeiGene Ltd. Recent Developments and Future Plans
- 2.6 Hinova Pharmaceuticals
- 2.6.1 Hinova Pharmaceuticals Details
- 2.6.2 Hinova Pharmaceuticals Major Business
- 2.6.3 Hinova Pharmaceuticals Targeted Protein Degradation Drug Product and Solutions
- 2.6.4 Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Hinova Pharmaceuticals Recent Developments and Future Plans
- 2.7 Haisco Pharmaceutical
- 2.7.1 Haisco Pharmaceutical Details
- 2.7.2 Haisco Pharmaceutical Major Business
- 2.7.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Product and Solutions
- 2.7.4 Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Haisco Pharmaceutical Recent Developments and Future Plans
- 2.8 Nurix
- 2.8.1 Nurix Details
- 2.8.2 Nurix Major Business
- 2.8.3 Nurix Targeted Protein Degradation Drug Product and Solutions
- 2.8.4 Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Nurix Recent Developments and Future Plans
- 2.9 Kymera Therapeutics
- 2.9.1 Kymera Therapeutics Details
- 2.9.2 Kymera Therapeutics Major Business
- 2.9.3 Kymera Therapeutics Targeted Protein Degradation Drug Product and Solutions
- 2.9.4 Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Kymera Therapeutics Recent Developments and Future Plans
- 2.10 C4 Therapeutics
- 2.10.1 C4 Therapeutics Details
- 2.10.2 C4 Therapeutics Major Business
- 2.10.3 C4 Therapeutics Targeted Protein Degradation Drug Product and Solutions
- 2.10.4 C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 C4 Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Targeted Protein Degradation Drug Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Targeted Protein Degradation Drug by Company Revenue
- 3.2.2 Top 3 Targeted Protein Degradation Drug Players Market Share in 2025
- 3.2.3 Top 6 Targeted Protein Degradation Drug Players Market Share in 2025
- 3.3 Targeted Protein Degradation Drug Market: Overall Company Footprint Analysis
- 3.3.1 Targeted Protein Degradation Drug Market: Region Footprint
- 3.3.2 Targeted Protein Degradation Drug Market: Company Product Type Footprint
- 3.3.3 Targeted Protein Degradation Drug Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Targeted Protein Degradation Drug Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Targeted Protein Degradation Drug Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Targeted Protein Degradation Drug Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Targeted Protein Degradation Drug Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Targeted Protein Degradation Drug Consumption Value by Type (2021-2032)
- 6.2 North America Targeted Protein Degradation Drug Market Size by Application (2021-2032)
- 6.3 North America Targeted Protein Degradation Drug Market Size by Country
- 6.3.1 North America Targeted Protein Degradation Drug Consumption Value by Country (2021-2032)
- 6.3.2 United States Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 6.3.3 Canada Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Targeted Protein Degradation Drug Consumption Value by Type (2021-2032)
- 7.2 Europe Targeted Protein Degradation Drug Consumption Value by Application (2021-2032)
- 7.3 Europe Targeted Protein Degradation Drug Market Size by Country
- 7.3.1 Europe Targeted Protein Degradation Drug Consumption Value by Country (2021-2032)
- 7.3.2 Germany Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 7.3.3 France Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 7.3.5 Russia Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 7.3.6 Italy Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Targeted Protein Degradation Drug Market Size by Region
- 8.3.1 Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Region (2021-2032)
- 8.3.2 China Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 8.3.3 Japan Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 8.3.5 India Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 8.3.7 Australia Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Targeted Protein Degradation Drug Consumption Value by Type (2021-2032)
- 9.2 South America Targeted Protein Degradation Drug Consumption Value by Application (2021-2032)
- 9.3 South America Targeted Protein Degradation Drug Market Size by Country
- 9.3.1 South America Targeted Protein Degradation Drug Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Targeted Protein Degradation Drug Market Size by Country
- 10.3.1 Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
- 10.3.4 UAE Targeted Protein Degradation Drug Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Targeted Protein Degradation Drug Market Drivers
- 11.2 Targeted Protein Degradation Drug Market Restraints
- 11.3 Targeted Protein Degradation Drug Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Targeted Protein Degradation Drug Industry Chain
- 12.2 Targeted Protein Degradation Drug Upstream Analysis
- 12.3 Targeted Protein Degradation Drug Midstream Analysis
- 12.4 Targeted Protein Degradation Drug Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Targeted Protein Degradation Drug. Industry analysis & Market Report on Targeted Protein Degradation Drug is a syndicated market report, published as Global Targeted Protein Degradation Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Targeted Protein Degradation Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
